Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LEXICON PHARMACEUTICALS, INC. | SVP, Chief Commercial Officer | Restricted Stock Units | 227K | $239K | $1.05 | Feb 8, 2024 | Direct |
LEXICON PHARMACEUTICALS, INC. | SVP, Chief Commercial Officer | Stock Option (Right to Buy) | 227K | Feb 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LXRX | LEXICON PHARMACEUTICALS, INC. | Feb 8, 2024 | 2 | $0 | 4 | Feb 12, 2024 | SVP, Chief Commercial Officer |
LXRX | LEXICON PHARMACEUTICALS, INC. | Oct 9, 2023 | 1 | $0 | 4 | Oct 11, 2023 | SVP, Chief Commercial Officer |
LXRX | LEXICON PHARMACEUTICALS, INC. | Oct 9, 2023 | 0 | $0 | 3 | Oct 11, 2023 | SVP, Chief Commercial Officer |